Supervised Exercise for Opioid Use Disorder
(HELM Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether a supervised aerobic exercise program can aid individuals with Opioid Use Disorder (OUD). Participants will engage in a 12-week program with three weekly walking sessions to determine if regular exercise supports recovery. It targets those currently in opioid treatment or with mild OUD who exercise infrequently (less than 20 minutes, three times a week). Participants must be willing to visit the research center once a week for 12 weeks. The goal is to assess if exercise can effectively manage OUD. As an unphased trial, this study provides a unique opportunity to explore innovative recovery support through exercise.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, since participants must be on opioid maintenance treatment or have mild opioid use disorder, it seems likely that you can continue your current medications.
What prior data suggests that this supervised exercise intervention is safe for individuals with Opioid Use Disorder?
Research has shown that supervised exercise is usually safe and well-tolerated. In a study involving people undergoing opioid treatment, structured exercise improved fitness levels without major safety concerns. Aerobic exercise, such as walking, is also known to reduce anxiety and cravings, which can benefit those with opioid use disorder.
One study found that aerobic activity reduced substance use in animals, suggesting it might help humans as well. Another study discovered that people using substances felt exercise could replace the 'high' they sought from drugs.
While these findings are promising, exercise programs for opioid use disorder are still under study for safety and effectiveness. However, aerobic exercise, like walking, is generally considered a low-risk activity.12345Why are researchers excited about this trial?
Unlike the standard treatments for opioid use disorder, which often involve medication-assisted therapies like methadone or buprenorphine, the supervised exercise intervention focuses on physical activity as a form of therapy. This approach is unique because it harnesses the benefits of regular exercise, such as improving mental health and reducing cravings, without relying on pharmaceuticals. Researchers are excited about this treatment as it offers a holistic and potentially less stigmatizing way to support recovery, encouraging a healthier lifestyle that might enhance overall well-being and complement existing treatments.
What evidence suggests that supervised exercise might be an effective treatment for Opioid Use Disorder?
Research has shown that aerobic exercise might help people with opioid use disorder (OUD) by reducing cravings and improving health. In one study, participants reported that physical activity lessened their cravings and made them feel healthier. Another study suggested that adding exercise to opioid treatment can improve fitness. In animals, aerobic exercise reduced the use of opioids like morphine and heroin, indicating it might help decrease dependence. While the evidence is promising, more research is needed to fully understand exercise's effectiveness for OUD. Participants in this trial will engage in a supervised exercise intervention to further explore these potential benefits.12367
Who Is on the Research Team?
Meredith S Berry, PhD
Principal Investigator
University of Florida
Are You a Good Fit for This Trial?
This trial is for adults aged 21-64 with mild to severe Opioid Use Disorder, who are not very active physically and can visit the research center weekly for 12 weeks. They must be able to exercise safely as determined by a medical exam. Pregnant individuals, those in other exercise or weight loss programs, or with certain medical conditions like heart disease or uncontrolled diabetes cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants undergo baseline assessment before starting the intervention
Treatment
Participants engage in a 12-week supervised aerobic exercise program, completing 3 walking sessions per week
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Supervised Exercise Intervention
Supervised Exercise Intervention is already approved in United States, European Union, Canada for the following indications:
- Peripheral Artery Disease
- Symptomatic Peripheral Artery Disease
- Opioid Use Disorder (as part of comprehensive treatment)
- Peripheral Arterial Disease
- Cardiovascular Rehabilitation
- Chronic Conditions Management
- Cardiovascular Health
- Chronic Disease Management
- Mental Health Support
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Florida
Lead Sponsor